From: A lipidomic approach to the study of human CD4+ T lymphocytes in multiple sclerosis
No. | Sex | Age (years) | Diagnosis/classification | EDSS |
---|---|---|---|---|
MS1 | M | 35 | RRMS | 1.5 |
MS2 | F | 32 | RRMS | 3.5 |
MS3 | F | 27 | RRMS | 2.5 |
MS4 | F | 18 | RRMS | 3.0 |
MS5 | F | 35 | RRMS | 1.7 |
MS6 | F | 24 | RRMS | 3.9 |
MS7 | M | 35 | RRMS | 2.0 |
MS8 | M | 40 | RRMS | 2.3 |
HC1 | M | 37 | Healthy control | na |
HC2 | F | 28 | Healthy control | na |
HC3 | F | 30 | Healthy control | na |
HC4 | M | 48 | Healthy control | na |
HC5 | F | 32 | Healthy control | na |